Stellar Biotech Inc (SBOTF) 0.6700 $SBOTF Stellar

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Stellar Biotech Inc (SBOTF) 0.6700 $SBOTF

Stellar Biotechnologies, Inc. (Nasdaq:SBOT) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Wed Nov 04, 9:00AM CST
What:
SBOT: 3.60 (-0.22), NDAQ: 64.59 (-0.18)

Stellar Biotechnologies Announces Approval of NASDAQ Uplisting
Marketwired - Tue Nov 03, 3:15PM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , today announced that the Company has received approval for its common shares to begin trading on The NASDAQ Capital Market ("Nasdaq" .
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Announces Results of Special Meeting of Shareholders
Marketwired - Thu Oct 29, 2:04PM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , announces that a Special Meeting of Shareholders was held today, October 29, 2015 (the "Meeting" , at which a proposed change to the Company's Articles (bylaws) was approved.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies and Amaran Biotechnology Provide Update on Collaboration
Marketwired - Thu Oct 01, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , is pleased to provide an update on the Company's ongoing collaboration with privately-held Taiwan biopharmaceuticals manufacturer Amaran Biotechnology, Inc. ("Amaran" .
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market
Marketwired - Fri Aug 28, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , today announced that, subject to regulatory approval, the Company will proceed with a consolidation of its issued and outstanding common shares (the "Shares" on the basis of one (1) post-consolidated common Share for every ten (10) pre-consolidated Shares (the "Reverse Split" .
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Reports Third Quarter 2015 Financial Results and Operational Highlights
Marketwired - Mon Aug 10, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , an important immune-stimulating protein used in wide-ranging immunotherapy markets, today announced its financial results for the third fiscal quarter ended June 30, 2015.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Signs Collaboration Agreement to Expand KLH Aquaculture Operations
Marketwired - Tue Jul 28, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), a leading provider of Keyhole Limpet Hemocyanin (KLH) protein, today announced that the Company has entered into a collaboration agreement with Ostiones Guerrero SA de CV ("Ostiones" (the "Agreement" to secure a unique strategic site in Baja California, Mexico for the development of an additional aquaculture locale and expansion of Stellar KLH(TM) production to meet the increasing needs of its customers.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Retains The Ruth Group to Advance Communications Objectives
Marketwired - Thu Jul 09, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), a leading provider of Keyhole Limpet Hemocyanin (KLH) protein, a crucial component for the development of many novel immunotherapies, today announced that it has retained New York City-based investor and public relations agency The Ruth Group as its strategic communications advisors.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies to Present at 5thAnnual LD Micro Invitational
Marketwired - Mon Jun 01, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that Stellar executives will present at the 5th Annual LD Micro Invitational Conference, being held June 1-3, 2015 at the Luxe Sunset Boulevard Hotel, Los Angeles, CA.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies to Present at 2015 Marcum MicroCap Conference
Marketwired - Wed May 27, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that Company executives will present at the 2015 Marcum MicroCap Conference, being held May 27-28, 2015 at the Grand Hyatt in New York City, NY.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies' Immunology 2015 Poster Available Online
Marketwired - Fri May 15, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company's poster presentation at this week's IMMUNOLOGY 2015 conference, the Annual Meeting of the American Association of Immunologists (AAI), has been posted to the Company's website. http://tinyurl.com/n5hq43w.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Reports Second Quarter 2015 Financial Results
Marketwired - Mon May 11, 3:30PM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, today announced its financial results for the second fiscal quarter and six months ended March 31, 2015.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Presents Poster at Immunology 2015 on the Immunogenicity of Different Forms and Preparations of KLH
Marketwired - Thu Apr 30, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of results from preclinical studies analyzing the immunogenicity of different forms and preparations of Keyhole Limpet Hemocyanin (KLH), and relating to the Company's work in developing methods to identify the appropriate functional properties of KLH for use in immunotherapy and immunodiagnostic applications.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies and Neovacs S.A. Expand KLH Supply Relationship
Marketwired - Wed Apr 01, 1:00AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) and Neovacs S.A. ("Neovacs" (ALTERNEXT PARIS: ALNEV) today announced that the Companies have entered into an expanded supply agreement to meet Neovacs' requirements for Keyhole Limpet Hemocyanin (KLH), a primary component of Neovacs' proprietary Kinoid immunotherapy technology.
KLH.VN: 5.380 (-0.230)

First FDA Breakthrough Therapy Designation for KLH-Conjugate Immunotherapy Signals Key Step for Novel Carrier Molecule
Marketwired - Tue Mar 10, 4:32PM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" is encouraged that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for a KLH-based immunotherapy compound in the treatment of adult patients with EGFRvIII-positive glioblastoma being developed by Celldex Therapeutics, Inc.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Reports First Quarter 2015 Financial Results
Marketwired - Mon Feb 09, 7:30AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, announced financial results for the first quarter period ended December 31, 2014.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies to Present at Biotech Showcase(TM) 2015 Conference
Marketwired - Thu Jan 08, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that the Company's management team will present at the 7th Annual Biotech Showcase 2015 conference, being held at the Parc 55 Wyndham Hotel in San Francisco, CA, on Tuesday, January 13 at 2:30 p.m. PST.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies Reports Year-End 2014 Financial Results
Marketwired - Thu Nov 13, 9:17AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, has reported preliminary financial results for the year ended August 31, 2014.
KLH.VN: 5.380 (-0.230)

Stellar Biotechnologies and Araclon Biotech Sign Exclusive KLH Supply Agreement for Clinical Trials in Alzheimer's Active Immunotherapies
Marketwired - Tue Nov 11, 11:46AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) and Araclon Biotech SL ("Araclon" today announced that the companies have executed a definitive exclusive supply agreement to meet Araclon's Phase (II and III) clinical trial requirements for Keyhole Limpet Hemocyanin (KLH) used in Araclon's active immunotherapies against Alzheimer's disease.
KLH.VN: 5.380 (-0.230)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EmTech AI 2027 Puts AI Ambitions Through Reality Test

Updated Category News Views 27

A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....

Continue Reading
Early Dog Guarding Signs Matter Before a Sudden Growl

Updated Category News Views 121

A bowl, a chewed-up toy, or a patch of couch can turn tense in a heartbeat. That is why the useful part of Brian Manning's guidance is not some fantasy of making every dog endlessly tolerant; it is learning to notice discomfort while there is still room to back off safely. For anybody watching the pet-care and behavior-training field, this is the kind of plainspoken...

Continue Reading
Condo Downsizing Demands More Than a Price Check Today

Updated Category News Views 58

A smaller front door can hide a surprisingly large stack of obligations. That is the useful point in the HelloNation guidance featuring Chevy Chase real estate expert Lise Howe: downsizing into a condo is not merely a square-footage trade. It is a decision about recurring costs, building stewardship, daily friction, and whether the place still works when life gets less...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 128

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Dubai's 2028 Fire Congress Puts Global Safety Tech on Stage

Updated Category News Views 38

Fire engines, wildfires, dense towers, and AI are all colliding in Dubai's next big public-safety moment. The World Fire Congress has handed its 2028 host role to Dubai, making this the first time the biennial gathering of global fire and emergency-service leaders will land in the Middle East. That is not a quarterly earnings event, and nobody ought to pretend it is....

Continue Reading
PostalAnnex Adds Roseville Store as Owners Reach Three

Updated Category News Views 31

A third storefront from the same operators says more than a ribbon-cutting ever will. Aarondeep Hira and Manraj Sangha have opened a PostalAnnex in Roseville, California, their third Sacramento-area location after earlier operations in Sacramento and Antelope. For a franchise system, repeat ownership is the part worth noticing. It is not a guarantee of booming sales, and...

Continue Reading
Markley’s Lowell Campus Turns Data Land Into Arboretum

Updated Category News Views 279

Server halls rarely get credited with restoring a landscape, which is why Markley’s Lowell campus caught my eye. On November 18, 2026, the company said its Lowell data center campus had earned Level I arboretum accreditation from the ArbNet Arboretum Accreditation Program. ArbNet describes itself as the only international accreditation program specifically for arboreta,...

Continue Reading
Rokt's 164% Growth Shows Checkout Ads Have Real Muscle

Updated Category News Views 186

Checkout screens have become valuable real estate, and Rokt is planting a flag right in the middle of them. The New York ecommerce technology company landed on Deloitte's 2026 Technology Fast 500 after posting 164% revenue growth from 2022 through 2025. That is a meaningful number, not decorative corporate confetti, especially in a digital-ad market where plenty of...

Continue Reading
Shenzhen's Vertical Factories Put Robotics on Fast Track

Updated Category News Views 100

A truck climbing to a ninth-floor factory is the sort of detail that cuts through the usual innovation fog. Shenzhen's Honghualing industrial base in Nanshan is built around that odd-looking reality: keep engineers, component makers, automated lines and test customers stacked close together, then squeeze time out of the process. For anybody watching robotics, LiDAR and...

Continue Reading
FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 75

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Update: Heroes Made Joins AWS Marketplace for Schools

Updated Category News Views 120

Heroes Made's Significant Partnership with GG4L Heroes Made, a top provider of Social and Emotional Learning (SEL) solutions for students, proudly announces its incorporation into the AWS Marketplace, specifically as part of Global Grid for Learning's (GG4L) SchoolDay Collection. This progressive collaboration aims to streamline how schools access and utilize effective...

Continue Reading
Palisade Bio Secures $138 Million to Advance Clinical Programs

Updated Category News Views 173

Palisade Bio Secures Substantial Funding to Propel Clinical Trials Palisade Bio, Inc. (Nasdaq: PALI), a clinical-stage biopharmaceutical company dedicated to innovating therapies for autoimmune and inflammatory diseases, recently announced the successful closing of an impressive public offering, which raised gross proceeds of approximately $138 million. This significant...

Continue Reading
Enlight's Snowflake A Project Boosts Renewable Energy Capacity

Updated Category News Views 46

Enlight Renewable Energy's New Power Purchase Agreement Enlight Renewable Energy, a noteworthy player in the renewable energy sector, recently announced exciting developments regarding its U.S. subsidiary, Clenera. They have successfully signed a power purchase agreement (PPA) with Arizona Public Service (APS) for the Snowflake A Project, which aims to bolster clean...

Continue Reading
BigBear.ai Faces Investigation Amidst Financial Restatement Concerns

Updated Category News Views 446

BigBear.ai Holdings Under Investigation BigBear.ai Holdings, Inc. (NYSE: BBAI) is currently the focus of an investigation initiated by legal representatives. This comes as a response to growing concerns among investors regarding potential inaccuracies within the company’s financial reporting. Recent disclosures made by BigBear indicate that their financial statements...

Continue Reading
Morgan Stanley's CEO Ted Pick Ascends to Chairman Role

Updated Category News Views 90

Ted Pick Takes the Helm as Chairman of Morgan Stanley In an exciting leadership development, Morgan Stanley (NYSE: MS) has named its current CEO, Edward (Ted) Pick, as the new Chairman of the Board, effective January 1, 2025. This transition comes as the firm prepares for the retirement of the current Chairman, James Gorman, who will take on the honorary title of Chairman...

Continue Reading